Press Release: MicroPulse Technologies : IRIDEX Announces Proprietary MicroPulse™ Technology For Treatment Of Eye Diseases Caused By Diabetes And Age-Related Macular Degeneration Featured On 'American Health Front' Program

MOUNTAIN VIEW, Calif., April 22, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that an educational story based on its innovative MicroPulse™ technology for the treatment of diabetic macular edema (DME) and age-related macular degeneration (AMD), was recently...